Guillain-Barré Syndrome in an Australian State Using Both mRNA and Adenovirus-Vector SARS-CoV-2 Vaccines.

Osowicki, Joshua; Morgan, Hannah; Harris, Adele; Crawford, Nigel W; Buttery, Jim P; Kiers, Lynette

Osowicki, Joshua; Morgan, Hannah; Harris, Adele; Crawford, Nigel W; Buttery, Jim P; Kiers, Lynette.

Afiliação

Osowicki J; Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Morgan H; Department of General Medicine, Royal Children's Hospital Melbourne, Melbourne, VIC, Australia.
Harris A; Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.
Crawford NW; Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Buttery JP; Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Kiers L; Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Ann Neurol ; 90(5): 856-858, 2021 11.

Article em En | MEDLINE | ID: mdl-34528279

Assuntos

COVID-19; Síndrome de Guillain-Barré; Adenoviridae; Austrália; Vacinas contra COVID-19; Humanos; RNA Mensageiro; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Guillain-Barré / COVID-19 Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Ann Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google